Physician profile
Jevin Yabut
NPI 1366062390
$1,739.84
in general payments reported to CMS, 2019-2025
13 companies · $1,332 in 2025
The $1,332 reported for 2025 was more than what 89% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $408 · 2025: $1,332.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,606 · Education: $134.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,605.58 |
| Education | $134.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $372.74 | 2024-2025 | Ensite, Cardiomems, Coroflow |
| Recor Medical INC | $294.57 | 2025 | Paradise Ultrasound Renal Denervation System |
| Bridgebio Pharma, INC. | $193.53 | 2025 | Attruby |
| Boston Scientific Corporation | $158.95 | 2024-2025 | Avvigo Guidance System, Watchman Flx |
| Shockwave Medical, INC | $143.66 | 2025 | |
| Amgen INC. | $138.49 | 2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $119.81 | 2025 | Lifevest |
| Abiomed | $113.97 | 2025 | |
| Edwards Lifesciences Corporation | $76.39 | 2025 | Evoque |
| Atricure, INC. | $70.97 | 2025 | Synergy Ablation System |
| E.R. Squibb & Sons, L.L.C. | $22.55 | 2025 | Camzyos |
| Grifols USA, LLC | $20.23 | 2025 | Prolastin-C Liquid |
| Merck Sharp & Dohme LLC | $13.98 | 2025 | Verquvo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jevin Yabut listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.